Actively Recruiting

Early Phase 1
Age: 55Years +
MALE
ID05657990

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Led by Hackensack Meridian Health · Updated on 2026-02-10

46

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate whether the use of Tamsulosin can reduce the high rate of postoperative urinary retention (POUR) in older men undergoing thoracic cancer surgery. POUR is a common issue, especially in older men with enlarged prostates, leading to urinary tract infections, discomfort, and longer hospital stays. This pilot study focuses on men aged 55 and older scheduled for oncological thoracic surgery to see if Tamsulosin can help lower POUR incidence and identify when normal urinary function returns after surgery. Participants will receive a prescription for Tamsulosin at a dose of 0.4 mg daily, starting seven days before their planned surgery and continuing up to the day of surgery. They will take the medication with a meal and record their daily usage in a diary. After surgery, bladder function will be monitored using ultrasound to measure urine volume and residual urine. If spontaneous urination does not occur or excess urine remains, standard bladder management including intermittent catheterization may be applied based on specific guidelines. During the study, researchers will observe and record whether participants can urinate spontaneously within 6 to 8 hours after surgery, the timing and volume of urination within 24 hours, and the amount of residual urine. Those unable to urinate spontaneously may receive catheter interventions. The study will include regular assessments using a BladderScanner and follow participants until urinary function resumes. The total study duration varies depending on surgery and recovery timelines.

CONDITIONS

Brief Title

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Who Can Participate

Age: 55Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male sex
  • 55 years of age or older
  • Scheduled for a thoracic oncological surgical procedure for suspected or confirmed cancer
  • Surgery scheduled at least 7 days after giving consent
Not Eligible

You will not qualify if you...

  • Currently using Tamsulosin
  • Known allergy to Tamsulosin or sulfa drugs
  • Current use of Boceprevir
  • Resting systolic blood pressure less than 100 mm Hg
  • Orthostatic hypotension with more than 20 mm Hg systolic or 10 mm Hg diastolic drop after standing for 2 minutes
  • History of hypotension
  • Known congestive heart failure or valvular heart disease
  • History of prior prostate surgery such as prostatectomy or trans-urethral resection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Run-in Period

Duration - 7 days

Participants take Tamsulosin daily for seven days prior to their scheduled thoracic oncological surgery.

Daily medication intake with a diary to record usage

Surgery and Immediate Post-operative Care

Duration - Up to 24 hours post surgery

Participants undergo thoracic oncological surgery followed by bladder ultrasound approximately six hours after surgery to assess urinary retention. Bladder management interventions are provided if needed based on ultrasound results and ability to void.

1 post-surgical assessment visit (in-person)

Trial Site Locations

Total: 4 locations

1

Ocean University Medical Center

Brick, New Jersey, United States, 08724

Actively Recruiting

2

South Ocean University Medical Center

Manahawkin, New Jersey, United States, 08050

Actively Recruiting

3

Jersey Shore University Medical Center

Neptune City, New Jersey, United States, 07753

Actively Recruiting

4

Riverview Medical Center

Red Bank, New Jersey, United States, 07701

Actively Recruiting

Loading map...

Research Team

D

Denise Theiler, RN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Similar Trials

Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Colo...

Urinary Retention

Actively Recruiting

1 location

EVA-study on Catheter Selection Criteria at Start of Self-ca...

Neurogenic Bladder Disorder

Actively Recruiting

1 location

Evaluation of the Effect of Catheter Duration on Prostate La...

Urinary Retention

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here